Animesh Garg is an Assistant Professor at the School of Interactive Computing at Georgia Tech, where he leads the People, AI, and Robotics (PAIR) research group . He holds a Senior Researcher position at Nvidia Research and has courtesy appointments at the University of Toronto and Vector Institute. Previously, he served as Chief Scientific Officer at Apptronik (2024-2025) and Senior Staff Research Scientist at Nvidia Research (2018-2024). Education : Ph.D. in Operations Research from UC Berkeley (2011-2016), MS in Computer Science and Industrial Engineering from Georgia Tech and University of Delhi. Research Focus : Building Generalizable Autonomy through Reinforcement Learning , Control Theory , and 3D Vision , with applications in Surgical Robotics , Self-Driving Labs , and Manufacturing . Key Article Themes : His recent work emphasizes Foundation Models for robotics, Differentiable Simulation , Language-Guided Autonomy , and Structured Inductive Biases in sequential decision-making. Scientific Awards : Stephen Fleming Early Career Professorship at Georgia Tech. Teaching : Courses on AI, Deep Reinforcement Learning, and Algorithmic Intelligence in Robotics at Georgia Tech. Labs & Collaborations : Affiliated with Institute for Robotics and Intelligent Machines (IRIM) and ML@GT at Georgia Tech; collaborates intensively with Nvidia Robotics.
Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Jungsang Kim is the Schiciano Family Distinguished Professor of Electrical and Computer Engineering and Professor of Physics at Duke University. He serves as Associate Director of the Duke Quantum Center and leads the Multifunctional Integrated Systems Technology group. Quantum Computing with Trapped Ions Quantum Information Science Photonic Device Development Quantum Communication Networks His research focuses on scalable quantum information processors using trapped atomic ions and advanced photonic technologies. Key innovations include microfabricated ion traps, optical MEMS, and cryogenic systems for quantum integration. Recent publications highlight trapped ion quantum simulation, high-fidelity gate design, and photonic error mitigation. His group develops practical quantum hardware and co-founded IonQ, the first publicly traded pure-play quantum computing company. Fellow, American Physics Society (2021) Stansell Family Distinguished Research Award (2016) Fellow, National Academy of Inventors Fellow, Optica (formerly OSA) Kim's work bridges quantum physics and engineering, with over 80 patents and leadership in Duke's quantum computing initiatives. He recently stepped down as IonQ's CTO while maintaining active research and strategic roles at Duke.
Wengong Jin is an Assistant Professor at the Khoury College of Computer Sciences, Northeastern University, and a visiting research scientist at the Eric and Wendy Schmidt Center at the Broad Institute. He holds a PhD from MIT CSAIL, advised by Prof. Regina Barzilay and Prof. Tommi Jaakkola. Research Interests: His work focuses on geometric and generative AI models for drug discovery, biology, and chemical engineering. Key areas include equivariant neural networks (e.g., FAFormer), diffusion models for binding energy prediction, antibody/enzyme design (RefineGNN, SurfPro), and molecular design through graph neural networks (Junction Tree VAE). He also explores domain generalization and systems for autonomous molecular discovery. Publications: His research has been published in top venues like NeurIPS, ICLR, ICML, Nature, Science, and Cell. Recent breakthroughs include discovering novel antibiotics using explainable AI and designing synergistic drug combinations for cancer treatment. Awards: He has received the BroadIgnite Award, Dimitris N. Chorafas Prize, and MIT EECS Outstanding Thesis Award for his contributions to computational biology and AI-driven drug discovery. Teaching: Currently teaches a PhD seminar on AI for Science, focusing on integrating machine learning into scientific discovery processes.
Massachusetts Institute of TechnologyUnited States
Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.
Robert J. Hamers is a Professor of Chemistry and the Steenbock Professor of Physical Science at the University of Wisconsin-Madison . He serves as the Director of the Center for Sustainable Nanotechnology , a multi-institutional collaboration, and is a Senior Editor for Accounts of Chemical Research . Additionally, he co-founded the startup Silatronix, Inc. and leads the ACS/UW-Madison Bridge to the Chemistry Doctorate Program . B.S. in Chemistry, University of Wisconsin-Madison (1980) Ph.D. in Chemistry, Cornell University (1986) Hamers' research focuses on surface chemistry, nanotechnology, and renewable energy , with specific interests in electrochemical energy storage, photoelectron emission mechanisms, and environmental impacts of nanomaterials . His group develops ultra-stable surface chemistries for energy devices and investigates charge-transfer processes at material interfaces . Recent publications highlight advances in diamond-based materials , organosilicon electrolyte additives , and environmental fate of nanomaterials . Scientific recognitions include the Wisconsin Distinguished Professor title. His work bridges fundamental surface science with applied technologies through collaborations with academic institutions, national laboratories, and industry partners like Dow Chemical . The Hamers Group actively trains graduate students and postdoctoral researchers in multidisciplinary approaches.
California Institute of Technology (Caltech)United States
Raul Astudillo Marban is a Postdoctoral Scholar Research Associate in the Department of Computing and Mathematical Sciences at Caltech, hosted by Professor Yisong Yue. He will join MBZUAI as a tenure-track Assistant Professor in August 2025. His research focuses on adaptive learning and decision-making in complex, data-intensive environments, with applications in personalized healthcare, engineering design, and scientific discovery. He earned his Ph.D. in Operations Research and Information Engineering from Cornell University under Professor Peter Frazier and holds an undergraduate degree in Mathematics from the University of Guanajuato and the Center for Research in Mathematics. His work integrates Bayesian optimization and machine learning to address real-world challenges such as protein engineering, plant breeding, and computational biology. Key contributions include steering generative models with experimental data, preferential multi-objective optimization, and cost-aware Bayesian strategies. He has received recognition as a Rising Star in Management Science and Engineering (Stanford) and a Rising Star in Data Science (University of Chicago/UCSD). Recent research highlights include optimizing protein fitness through generative models, active learning in directed evolution, and Bayesian optimization for budget allocation in agriculture. His publications span top venues like NeurIPS, Nature Communications, and TMLR. He actively recruits students/researchers for projects in machine learning and optimization.
Weiping Tang is a Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison, holding the Janis Apinis Professorship in the School of Pharmacy and the Vilas Distinguished Achievement Professorship. He also serves as Director of the Medicinal Chemistry Center at the School of Pharmacy and maintains a faculty appointment with the Department of Chemistry in the College of Letters and Science. Janis Apinis Professor of Pharmaceutical Sciences Vilas Distinguished Achievement Professor Director of Medicinal Chemistry Center Faculty Appointment with Department of Chemistry Dr. Tang received his B.S. in Chemistry from Peking University in 1997, M.S. in Chemistry from New York University in 1999, Ph.D. in Organic Chemistry from Stanford University in 2005, and completed a postdoctoral fellowship in Medicinal Chemistry, Chemical Biology and Drug Discovery at Harvard University in 2007. Dr. Tang's research program focuses on drug discovery for cancer, infectious diseases, and neurodegenerative disorders through three interconnected areas: Organic Synthesis (advancing glycoscience through novel carbohydrate synthesis technologies), Medicinal Chemistry (developing small molecules that selectively remove disease-associated proteins), and Chemical Biology (dissecting biological pathways using novel small molecule probes). His group operates as an interdisciplinary team where chemists and biologists collaborate closely on drug discovery projects, with particular emphasis on developing novel degraders for disease-causing proteins. Analysis of Dr. Tang's publication record reveals a significant shift toward targeted protein degradation technologies, particularly PROTACs and molecular glues, while maintaining strong foundations in carbohydrate chemistry. His most impactful recent work includes developing degraders for extracellular and membrane proteins (previously considered 'undruggable'), creating rapid synthesis platforms like Rapid-TAC and Rapid-Glue, and advancing understanding of ternary complex formation for novel PROTAC design. His research spans both chemical methodology development and therapeutic applications across multiple disease areas. Vilas Distinguished Achievement Professorship Janis Apinis Professorship Numerous high-impact publications in leading chemistry and pharmacology journals Editor's pick and hot paper designations for significant contributions Dr. Tang mentors a diverse team of graduate students, postdoctoral fellows, and staff scientists with expertise spanning synthetic chemistry, medicinal chemistry, carbohydrate chemistry, computational chemistry, biochemistry, and cell biology. His group has developed innovative platforms for the rapid synthesis of protein degraders and has made significant contributions to understanding the mechanisms of action for these novel therapeutics. Current research includes developing selective degraders for cancer targets like RIPK1, BRD4, and CARM1, as well as advancing delivery systems for clinical translation. The Tang Research Group maintains state-of-the-art facilities within the School of Pharmacy at UW-Madison, equipped for comprehensive chemical synthesis, compound characterization, and biological evaluation. The group actively collaborates with researchers across campus and with industry partners to advance discoveries toward clinical applications, with particular focus on cancer therapeutics and protein degradation technologies.
University of California , Santa Barbara (UCSB)United States
Ambuj K. Singh is a Distinguished Professor of Computer Science at the University of California, Santa Barbara (UCSB), with a part-time appointment in the Biomolecular Science and Engineering Program. He holds a PhD from the University of Texas at Austin (1989), an MS from Iowa State University (1984), and a BTech from the Indian Institute of Technology, Kharagpur (1982). His campus affiliations include the Center for Bio-Image Informatics, Information Network Academic Research Center, and IGERT on Network Science. PhD, University of Texas at Austin, 1989 M.S., Iowa State University, 1984 B.Tech., Indian Institute of Technology, Kharagpur, 1982 Research interests span network science, machine learning, and bioinformatics, with a focus on graph-based methodologies. His work addresses: Data-centric modeling of dynamic networks Representation learning and explainability in graph neural networks Network analysis in social systems and biological networks Applications in drug discovery and brain sciences Geometry-preserving distance metrics for data integrity Recent publications highlight advancements in counterfactual explanations, GNN benchmarking, molecular graph pretraining, and self-attention for event detection. Scientific contributions include: Founding Acelot, Inc., an in silico drug discovery company Editorial roles at IEEE Transactions on Knowledge & Data Engineering and BMC Journal of Clinical Bioinformatics NSF-IGERT (2013-2018), ARL-funded Information Networks Academic Research Center (2009-2014), and US Army MURI grants Advising has involved mentoring over 50 graduate/postdoctoral students, including 30+ PhD candidates. He leads a multidisciplinary research group at UCSB and collaborates with off-campus entities like Acelot, Inc.
Matthew L Becker is the Hugo L Blomquist Distinguished Professor of Chemistry at Duke University, with additional appointments in Mechanical Engineering and Material Science, and Biomedical Engineering. His research focuses on polymer chemistry, bioconjugate chemistry, molecular imaging, additive manufacturing, and degradable materials for bone, soft tissue, neural, and vascular tissue engineering. Education: B.S. from Northwest Missouri State University (1998), M.A. (2000) and Ph.D. (2003) from Washington University in St. Louis Research interests include developing tunable degradable polymers for flexible electronics, tissue engineering (bone, neural, vascular), and additive manufacturing. His group is pioneering 3D printing of bioresorbable medical devices and custom inks for biomaterials. Recent work explores stereochemistry-dependent polymer properties, mechanochromism, and machine learning-driven biomaterials design. Key applications: Drug delivery systems Biodegradable adhesives Tissue regeneration scaffolds Scientific honors include: Fellow, National Academy of Inventors (2022) Fellow, American Chemical Society (2020) Carl S. Marvel Award in Creative Polymer Chemistry (2019) Fellow, American Institute for Medical and Biomedical Engineering (2018) Fellow, Royal Society of Chemistry (2017) Biomacromolecules/Macromolecules Young Investigator Award (2015) He teaches advanced courses in mechanical engineering and polymer chemistry, with a focus on 3D printing and biomaterials. His group has developed novel medical devices including resorbable suture anchors, hernia mesh coatings, and neuroprosthetic scaffolds.
John Paisley is an Associate Professor of Electrical Engineering at Columbia University's Fu Foundation School of Engineering and Applied Science, and a member of Columbia's Data Science Institute (DSI). He holds a B.S., M.S., and Ph.D. in Electrical and Computer Engineering from Duke University (2004-2010), followed by postdoctoral research in Computer Science at Princeton University and UC Berkeley. His research focuses on Bayesian models, posterior inference techniques for Big Data, and applications in data analysis, recommendation systems, information retrieval, and compressed sensing. He has pioneered methods like Bayesian Gaussian Process ODEs and Double Normalizing Flows, with recent work emphasizing uncertainty quantification in environmental modeling and neuroimaging analysis. His collaborative workflows (e.g., bneR ) address air pollution exposure and PM2.5 concentration uncertainties, combining Bayesian nonparametric ensembles with geospatial data. He has also developed frameworks for neural network interpretability, image denoising, and compressed sensing MRI. Paisley's work bridges statistical theory and applied machine learning, with applications in healthcare, environmental science, and geophysics. His academic contributions include over 50 publications since 2016, spanning topics like deep metric learning, adversarial learning, and variational inference optimization. He maintains an active research group and serves on editorial boards for machine learning and signal processing journals.
Massachusetts Institute of TechnologyUnited States
Martin Z. Bazant is the E. G. Roos (1944) Professor of Chemical Engineering and Professor of Mathematics at the Massachusetts Institute of Technology (MIT), holding the Digital Learning Officer role in the Department of Chemical Engineering. His research focuses on mathematical modeling of electrochemical systems, transport phenomena, and applied mathematics, with significant contributions to battery technology and electrochemical energy storage. He is affiliated with MIT’s Department of Mathematics and the MIT Energy Initiative (MITEI), leading initiatives like the Center for Battery Sustainability and D3BATT. Education: Ph.D. from Harvard University (1997), M.S. and B.S. from the University of Arizona (1993, 1992). His work bridges theory and application, addressing challenges in lithium-ion batteries, solid-state systems, and electrolyte dynamics. Notable achievements include pioneering studies on coupled ion-electron transfer mechanisms and phase separation in battery materials. He is an elected member of the National Academy of Engineering (2025) and a Fellow of the Electrochemical Society (2023). As an educator, he develops MOOCs on transport phenomena and contributes to digital learning initiatives. His research group explores advanced battery diagnostics, machine learning for materials science, and environmental applications of electrochemical processes. Key collaborations include startups like Lithios, Inc., and leadership roles in professional societies such as the International Electrokinetics Society.
Dr. Kai Gong is an Assistant Professor of Civil and Environmental Engineering at Rice University, with affiliations at the Rice Advanced Materials Institute and Ken Kennedy Institute. His research focuses on sustainable infrastructure materials, environmental sustainability, and materials science. He holds a Ph.D. in Civil & Environmental Engineering and Materials Science from Princeton University, an MEngSci from Monash University (Australia), and dual B.S. degrees from Monash University and Central South University (China). Research Interests: Development of durable, sustainable infrastructure materials Waste encapsulation and conversion to value-added products Carbon mineralization and utilization Advanced characterization techniques (synchrotron/neutron scattering) Data-driven modeling and atomistic simulations Notable Awards: 2023 Le Chatelier Medal (Cement and Concrete Research) 2024 Giatec Award for Best Paper in Sustainability Walbridge Fund Graduate Award (2019) His work integrates computational methods (e.g., molecular dynamics) with experimental techniques to address decarbonization challenges in infrastructure. The Gong Research Group actively seeks motivated researchers for opportunities in sustainable materials innovation.
David R. Koes is an Associate Professor in the Department of Computational and Systems Biology at the University of Pittsburgh, affiliated with the School of Medicine. He holds roles such as Associate Director of the Joint CMU-Pitt Computational Biology PhD Program (CPCB) and is involved in multiple graduate programs including Intelligent Systems and Computational Biomedicine. His research focuses on developing computational algorithms and systems for drug discovery, emphasizing open-source software and machine learning applications in biomedical data. Koes teaches courses like MSCBIO2025 (Bioinformatics Programming in Python) and MSCBIO2065 (Scalable Machine Learning for Big Data Biology). He has secured NIH funding (R35GM140753) and collaborated on projects with institutions like NVIDIA and Google Cloud. His lab develops tools such as GNINA, Pharmit, and 3Dmol.js, and actively contributes to open drug discovery initiatives. Education: PhD in Computer Science from Carnegie Mellon University (CMU). Research Interests: Leveraging computation and AI for drug design, molecular docking, pharmacophore modeling, and open science. Specific areas include developing scalable machine learning pipelines, virtual screening systems, and tools for 3D molecular analysis. Grants and Funding: Current NIH R35 grant and prior support from NSF, Relay Therapeutics, and others. His work emphasizes translating computational methods into practical drug discovery solutions. Lab and Teams: Directs a lab focused on computational drug discovery, collaborating with multiple academic and industry partners. Supervises graduate students and postdocs in projects spanning AI-driven drug design, molecular modeling, and software development.
University of California, Los AngelesUnited States
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
